Jefferies Starts Insmed (INSM) at Buy
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $106.06 +1.26%
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 18
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 18
Join SI Premium – FREE
Jefferies analyst Faisal Khurshid initiates coverage on Insmed (NASDAQ: INSM) with a Buy rating and a price target of $228.00.
For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.
Shares of Insmed closed at $139.50 yesterday.
You May Also Be Interested In
- Palvella Therapeutics adds Matt Pauls to its board of directors
- BNP Paribas Exane Starts Honeywell Aerospace Inc (HONA) at Neutral
- Benchmark Starts Rocket Cos Inc. (RKT) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
